Depression, Anxiety, Stress and Social Isolation in Hepatitis Patients

Pegah Ahmadi Sarbarzeh, Saba Karimi, Milad Jalilian, Hadis Mosafer


Hepatitis is a complex and chronic liver disorder. Due to the nature of the disease, these patients experience various levels of social isolation, anxiety, and depression. Therefore, this study was conducted to evaluate depression, anxiety, stress, and social isolation in patients with hepatitis B and C in Kermanshah. This study is descriptive-analytic research, the participants were the patients with hepatitis, who referred to liver disease center. Data collection was with Russell social isolation questionnaire and DASS-21 questionnaire. The questionnaires were completed by the patients. 67.3% of the patients were male. The mean age was 41.02 ± 12.4 years, and the majority of the participants were married (143; 67.8%). The results showed that there is a direct and significant relationship between social isolation with depression, anxiety, and stress (P=0.001, P=0.001, P=0.001). In addition, results showed that there is a significant difference between the mean depression scores and age (P=0.048). Also, the results showed that there is a significant difference in the mean score of social isolation and education level (P=0.038). There is no significant difference between the other variables with depression, anxiety, stress, and social isolation (P>0.05). These results showed that there is a relationship between social isolation with anxiety, stress, and depression. Also, anxiety, stress, and depression in hepatitis patients are related to age and education level. So, it is suggested to provide effective programs in the care of these patients.


Doi: 10.28991/SciMedJ-2020-0204-5

Full Text: PDF


Hepatitis; Depression; Anxiety; Stress; Social Isolation.


Keramat, F., Mamani, M., Torabian, S., & Aliparast Dostkohi, M. (2013). Assessment and Comparison of Health-Related Quality of Life in Chronic Hepatitis B and C Patients with Healthy Persons in Hamadan Province. Avicenna Journal of Clinical Medicine, 20(2), 151-159.

Organization WH. Hepatitis; (2020). Available online: (Accessed on 14 April 2020).

Hasanpour, D. A. (2014). The Concept Of Self-Care In Patients Diagnosed With Chronic Hepatitis: A Rogers Evolutionary Approach. The Journal of Urmia Nursing and Midwifery Faculty, 12(6):477-90.

Kruszon-Moran, D., Paulose-Ram, R., Martin, C. B., Barker, L. K., & McQuillan, G. (2020). Prevalence and trends in hepatitis B virus infection in the United States, 2015–2018. NCHS Data Brief, no 361 Hyattsville, MD: National Center for Health Statistics 2020.

Hofstraat, S. H. I., Falla, A. M., Duffell, E. F., Hahné, S. J. M., Amato-Gauci, A. J., Veldhuijzen, I. K., & Tavoschi, L. (2017). Current prevalence of chronic hepatitis B and C virus infection in the general population, blood donors and pregnant women in the EU/EEA: a systematic review. Epidemiology and Infection, 145(14), 2873–2885. doi:10.1017/s0950268817001947.

Falla, A. M., Hofstraat, S. H. I., Duffell, E., Hahné, S. J. M., Tavoschi, L., & Veldhuijzen, I. K. (2018). Hepatitis B/C in the countries of the EU/EEA: a systematic review of the prevalence among at-risk groups. BMC Infectious Diseases, 18(1). doi:10.1186/s12879-018-2988-x.

Tang, L. S. Y., Masur, J., Sims, Z., Nelson, A., Osinusi, A., Kohli, A., … Kottilil, S. (2016). Safe and effective sofosbuvir-based therapy in patients with mental health disease on hepatitis C virus treatment. World Journal of Hepatology, 8(31), 1318. doi:10.4254/wjh.v8.i31.1318.

Zhu, H.-P., Gu, Y.-R., Zhang, G.-L., Su, Y.-J., Wang, K., Zheng, Y.-B., & Gao, Z.-L. (2016). Depression in patients with chronic hepatitis B and cirrhosis is closely associated with the severity of liver cirrhosis. Experimental and Therapeutic Medicine, 12(1), 405–409. doi:10.3892/etm.2016.3271.

Wang, L.-J., Chen, S.-W., Chen, C.-K., Yen, C.-L., Chang, J.-J., Lee, T.-S., … Chien, R.-N. (2016). Treatment-emergent depression and anxiety between peginterferon alpha-2a versus alpha-2b plus ribavirin for chronic hepatitis C. BMC Psychiatry, 16(1). doi:10.1186/s12888-016-1135-8.

Mast, E. E., Margolis, H. S., Fiore, A. E., Brink, E. W., Goldstein, S. T., Wang, S. A., Moyer, L. A, Bell, B. P., & Alter, M. J. (2005). A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents. MMWR Recommendations and reports: Morbidity and mortality weekly report Recommendations and reports, 54(Rr-16):1-31. doi:10.1037/e548682006-001.

Hajarizadeh, B., Richmond, J., Ngo, N., Lucke, J., & Wallace, J. (2016). Hepatitis B-Related Concerns and Anxieties Among People With Chronic Hepatitis B in Australia. Hepatitis Monthly, 16(6). doi:10.5812/hepatmon.35566.

Härter, M., Reuter, K., Aschenbrenner, A., Schretzmann, B., Marschner, N., Hasenburg, A., & Weis, J. (2001). Psychiatric disorders and associated factors in cancer: results of an interview study with patients in inpatient, rehabilitation and outpatient treatment. European Journal of Cancer, 37(11), 1385–1393. doi:10.1016/s0959-8049(01)00136-8.

Zacks, S., Beavers, K., Theodore, D., Dougherty, K., Batey, B., Shumaker, J., … Fried, M. W. (2006). Social Stigmatization and Hepatitis C Virus Infection. Journal of Clinical Gastroenterology, 40(3), 220–224. doi:10.1097/00004836-200603000-00009.

Blasiole, J. A., Shinkunas, L., LaBrecque, D. R., Arnold, R. M., & Zickmund, S. L. (2006). Mental and physical symptoms associated with lower social support for patients with hepatitis C. World Journal of Gastroenterology, 12(29), 4665. doi:10.3748/wjg.v12.i29.4665.

Kesen, O., Kani, H. T., Yanartas, O., Aykut, U. E., … Gok, B. (2019). Evaluation of depression, anxiety and quality of life in hepatitis C patients who treated with direct acting antiviral agents. The Turkish Journal of Gastroenterology, 30(9), 801–806. doi:10.5152/tjg.2019.18679.

Vabo, I. L. C., Ferreira, L. E. V. V. de C., & Pace, F. H. L. (2016). Depressive Episode Incidence in Patients with Chronic Hepatitis C Treated with Pegylated Interferon and Ribavirin. Arquivos de Gastroenterologia, 53(1), 20–24. doi:10.1590/s0004-28032016000100005.

Ataei, B., Javadi, A. A., Salehi, M., Mortazavi, R., Kassaian, N., Babak, A., Nokhodian, Z., & Ataei, M. (2012). Relative Frequency of Depression and Anxiety in Chronic Hepatitis C Patients. Journal of Isfahan Medical School, 29(165).

Tran, T. D., Tran, T., & Fisher, J. (2013). Validation of the depression anxiety stress scales (DASS) 21 as a screening instrument for depression and anxiety in a rural community-based cohort of northern Vietnamese women. BMC Psychiatry, 13(1). doi:10.1186/1471-244x-13-24.

Antony, M. M., Bieling, P. J., Cox, B. J., Enns, M. W., & Swinson, R. P. (1998). Psychometric properties of the 42-item and 21-item versions of the Depression Anxiety Stress Scales in clinical groups and a community sample. Psychological Assessment, 10(2), 176–181. doi:10.1037/1040-3590.10.2.176.

Covic, T., Cumming, S. R., Pallant, J. F., Manolios, N., Emery, P., Conaghan, P. G., & Tennant, A. (2012). Depression and anxiety in patients with rheumatoid arthritis: prevalence rates based on a comparison of the Depression, Anxiety and Stress Scale (DASS) and the hospital, Anxiety and Depression Scale (HADS). BMC Psychiatry, 12(1). doi:10.1186/1471-244x-12-6.

Sahebi, A., Asghari, M., & Salari, R. (2005). Validation of Depression Anxiety and Stress Scale (DASS-1) for an Iranianpopulation. Journal of Develomental psychology, 1(4), 36-54.

Russell, D., Peplau, L. A., & Cutrona, C. E. (1980). The revised UCLA Loneliness Scale: Concurrent and discriminant validity evidence. Journal of Personality and Social Psychology, 39(3), 472–480. doi:10.1037/0022-3514.39.3.472.

Zarei, S., Memari, A. H., Moshayedi, P., & Shayestehfar, M. (2015). Validity and reliability of the UCLA loneliness scale version 3 in Farsi. Educational Gerontology, 42(1), 49–57. doi:10.1080/03601277.2015.1065688.

Zhang, S. X., Yang, P. C., Cai, Y. L., Lin Y., & Zou, Y. H. (2017). Cost-effectiveness of community-based treatment of chronic hepatitis B in China. Zhonghua liuxingbingxue zazhi, 38(7):860-7. doi:10.3760/cma.j.issn.0254-6450.2017.07.004.

Chahal, H. S., Peters, M. G., Harris, A. M., McCabe, D., Volberding, P., & Kahn, J. G. (2018). Cost-effectiveness of Hepatitis B Virus Infection Screening and Treatment or Vaccination in 6 High-risk Populations in the United States. Open Forum Infectious Diseases, 6(1). doi:10.1093/ofid/ofy353.

Liu, Y., Tang, K., Long, J., & Zhao, C. (2016). The association between hepatitis B self-awareness and depression: Exploring the modifying effects of socio-economic factors. Journal of Viral Hepatitis, 24(4), 330–336. doi:10.1111/jvh.12647.

Hu, C. G., Yuan, G. S., Huang, H. P., Liu, J. W., Zhou, Y. C., Ren, Y. Y., ... & Zhou, Y. P. (2017). Depression and anxiety caused by pegylated interferon treatment in patients with chronic hepatitis B and the therapeutic effects of escitalopram and alprazolam. Journal of Southern Medical University, 37(9), 1201-1205.

Adinolfi, L. E., Nevola, R., Rinaldi, L., Romano, C., & Giordano, M. (2017). Chronic Hepatitis C Virus Infection and Depression. Clinics in Liver Disease, 21(3), 517–534. doi:10.1016/j.cld.2017.03.007.

Simonetti, G., Gitto, S., Golfieri, L., Gamal, N., Loggi, E., Taruschio, G., … Andreone, P. (2018). Quality of life of hepatitis B virus surface antigen-positive patients with suppressed viral replication. European Journal of Gastroenterology & Hepatology, 30(1), 14–20. doi:10.1097/meg.0000000000000999.

Febrero, B., Ramírez, P., Martínez-Alarcón, L., Abete, C., Galera, M., Ríos, A., … Parrilla, P. (2018). Quality of Life and Group Psychological Intervention in Patients with Cirrhosis on Liver Transplant Waiting List. Transplantation Proceedings, 50(9), 2626–2629. doi:10.1016/j.transproceed.2018.04.013.

Henkel, H., Schmitz, M., Berghofer, G., Lang, A., Kager, A., Steiner, E., ... & Rudas, S. (2000). Social vulnerability, social isolation of chronic psychiatric patients. Wiener medizinische Wochenschrift (1946), 150(22), 449-453.

Holley, U. A. (2007). Social Isolation: A Practical Guide for Nurses Assisting Clients with Chronic Illness. Rehabilitation Nursing, 32(2), 51–58. doi:10.1002/j.2048-7940.2007.tb00152.x.

Kawase, K., Kondo, K., Saito, T., Shimasaki, A., Takahashi, A., Kamatani, Y., … Iwata, N. (2016). Risk factors and clinical characteristics of the depressive state induced by pegylated interferon therapy in patients with hepatitis C virus infection: A prospective study. Psychiatry and Clinical Neurosciences, 70(11), 489–497. doi:10.1111/pcn.12424.

Leutscher, P. D. C., Lagging, M., Buhl, M. R., Pedersen, C., Norkrans, G., … Langeland, N. (2010). Evaluation of depression as a risk factor for treatment failure in chronic hepatitis C. Hepatology, 52(2), 430–435. doi:10.1002/hep.23699.

He, Y., Gao, H., Li, X., & Zhao, Y. (2014). Psychological Stress Exerts Effects on Pathogenesis of Hepatitis B via Type-1/Type-2 Cytokines Shift toward Type-2 Cytokine Response. PLoS ONE, 9(8), e105530. doi:10.1371/journal.pone.0105530.

Burns, V. E., Carroll, D., Ring, C., Harrison, L. K., & Drayson, M. (2002). Stress, Coping, and Hepatitis B Antibody Status. Psychosomatic Medicine, 64(2), 287–293. doi:10.1097/00006842-200203000-00012.

Vu, T., Le, T., Dang, A., Nguyen, L., Nguyen, B., Tran, B., … Ho, R. (2019). Socioeconomic Vulnerability to Depressive Symptoms in Patients with Chronic Hepatitis B. International Journal of Environmental Research and Public Health, 16(2), 255. doi:10.3390/ijerph16020255.

Weinstein, A. A., Kallman Price, J., Stepanova, M., Poms, L. W., Fang, Y., Moon, J., … Younossi, Z. M. (2011). Depression in Patients with Nonalcoholic Fatty Liver Disease and Chronic Viral Hepatitis B and C. Psychosomatics, 52(2), 127–132. doi:10.1016/j.psym.2010.12.019.

Mirabdolhagh Hazaveh, M., Dormohammadi Toosi, T., Nasiri Toosi, M., Tavakoli, A., & Shahbazi, F. (2015). Prevalence and severity of depression in chronic viral hepatitis in Iran. Gastroenterology Report, 3(3), 234–237. doi:10.1093/gastro/gou091.

Alian, S., Masoudzadeh, A., Khoddad, T., Dadashian, A., & Mohammadpour, R. A. (2013). Depression in hepatitis B and C, and its correlation with hepatitis drugs consumption (interfron/lamivodin/ribaverin). Iranian Journal of Psychiatry and Behavioral Sciences, 7(1), 24.

Stewart, B., Mikocka-Walus, A., Morgan, J., Colman, A., Phelps, M., Harley, H., & Andrews, J. (2012). Anxiety and depression in Australian chronic hepatitis C outpatients: prevalence and predictors. Australasian Psychiatry, 20(6), 496–500. doi:10.1177/1039856212460597.

Aktuğ Demir, N., Celik, M., Kölgelier, Ş., Sümer, S., Demir, L. S., İnkaya, A. Ç., & Aksöz, S. (2013). Comparison of the level of Depression and Anxiety in Inactive Hepatitis B Carriers and Chronic Hepatitis B Patients. Turkish Journal of Psychiatry, 24(4): 248-252.

Golub, E. T. (2004). Screening for Depressive Symptoms Among HCV-Infected Injection Drug Users: Examination of the Utility of the CES-D and the Beck Depression Inventory. Journal of Urban Health: Bulletin of the New York Academy of Medicine, 81(2), 278–290. doi:10.1093/jurban/jth114.

Younossi, Z. M., Henry, L., Park, H., Adeyemi, A., & Stepanova, M. (2015). Depression and Chronic Hepatitis C (CH-C): A Common and Costly Association. American Journal of Gastroenterology, 110, S874–S875. doi:10.14309/00000434-201510001-02085.

Valizadeh, L., Zamanzadeh, V., Bayani, M., & Zabihi, A. (2017). The Social Stigma Experience in Patients With Hepatitis B Infection. Gastroenterology Nursing, 40(2), 143–150. doi:10.1097/sga.0000000000000223.

Hanan Najem Najaf, Dheyaa J. Kadhim, Ahmed J. Alkofee, & Dheyaa A. Al-Mashhadani. (2019). Depression, Anxiety and Stress Among a Sample of Chronic Hepatitis C Patients in AL-Najaf Province /Iraq. International Journal of Research in Pharmaceutical Sciences, 10(4), 3170–3177. doi:10.26452/ijrps.v10i4.1616.

Full Text: PDF

DOI: 10.28991/SciMedJ-2020-0204-5


Copyright (c) 2020 Pegah Ahmadi Sarbarzeh, Saba Karimi, Milad Jalilian, Hadis Mosafer